List of works - Rosanna Santoro

Peginterferon alfa-2b and ribavirin for 12 vs. 24 weeks in HCV genotype 2 or 3.

scientific article published in June 2005

An IL28B polymorphism determines treatment response of hepatitis C virus genotype 2 or 3 patients who do not achieve a rapid virologic response

scientific article published on 2 June 2010

Reduced IFNλ4 activity is associated with improved HCV clearance and reduced expression of interferon-stimulated genes

scientific article published on 23 December 2014

Inosine triphosphatase genetic variants are protective against anemia during antiviral therapy for HCV2/3 but do not decrease dose reductions of RBV or increase SVR

scientific article published on January 10, 2011

Limited use of interleukin 28B in the setting of response-guided treatment with detailed on-treatment virological monitoring

scientific article published on 21 July 2011

A randomized trial of amantadine and interferon versus interferon alone as initial treatment for chronic hepatitis C.

scientific article published in April 2001

Causes of portal venous thrombosis in cirrhotic patients: the role of genetic and acquired factors.

scientific article published in July 2005

The combination of daclatasvir and sofosbuvir for curing genotype 2 patients who cannot tolerate ribavirin

scientific article

Treatment optimization and prediction of HCV clearance in patients with acute HCV infection.

scientific article published on 12 April 2013

Sofosbuvir and ribavirin for genotype 2 HCV infected patients with cirrhosis: A real life experience.

scientific article published on 10 December 2016

IL28B CC-genotype association with HLA-DQB1*0301 allele increases the prediction of spontaneous HCV RNA clearance in thalassaemic HCV-infected patients

scientific article published in January 2011

Interleukin 28B polymorphisms as predictor of response in hepatitis C virus genotype 2 and 3 infected patients

scientific article published on December 2013

High doses of interferon in combination with ribavirin are more effective than the standard regimen in patients with HCV genotype 1 chronic hepatitis.

scientific article published in July 2002

Linkage analysis identifies gene carriers among members of families with hereditary nonpolyposis colorectal cancer

article

Erratum: Corrigendum: Reduced IFNλ4 activity is associated with improved HCV clearance and reduced expression of interferon-stimulated genes

scientific article published in Nature Communications

Interleukin-28B genetic variants in untreated Italian HCV-infected patients: a multicentre study